News

Coughlin Stoia Geller Rudman & Robbins (Coughlin Stoia) has filed a class action in the US District Court for the Eastern District of Pennsylvania on behalf of purchasers

Oculus Innovative Sciences (Oculus) has entered into a new strategic partnership with V&M Industries for non-exclusive rights to market Microcyn-based skin and wound care over-the-counter products in the

Mylan has reported that its Indian subsidiary, Matrix Laboratories has received tentative approval from the FDA under the President’s Emergency Plan for AIDS Relief (PEPFAR) for its New

AEterna Zentaris has reported that Keryx, its partner and licensee for perifosine in the North American market, has received orphan-drug designation for the compound from the FDA for

Avaxia Biologics has been awarded a phase I SBIR grant from the National Institute of Dental and Craniofacial Research to support the development of a novel antibody therapeutic

The US Food and Drug Administration (FDA) has asked the manufacturers of the drug promethazine to include a boxed warning regarding the injectable form of the drug. The

Ozonics International has announced that a study exploring the healing of diabetic skin ulcers using topical oxygen/ozone gas mixtures could not proceed to completion and was now abandoned.

PPD has opened its global central lab facility in Singapore, strengthening its ability to provide biopharmaceutical clients an extensive range of customised laboratory services in Southeast Asia. Steve

Clariant will build an ethoxylation plant in Dayabay, south of Guangzhou. The plant will be operational in early 2011 and will enable Clariant to meet increasing demand from